Furthermore, due to a paucity of reports of DOCK8-deficiency in the Pacific regions, it is possible the clinical phenotype of affected individuals in this geographical area may differ from that reported for DOCK8-deficiency in the Americas, Europe and the Middle East [18, 29, 31, 32]. This evidence concerns the gene DOCK8 and hyperinsulinemic hypoglycemia, familial, 4.